Simplex Trading’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
Simplex Trading's OBIO Position: Q3 2026 in Review
Simplex Trading reduced its Orchestra BioMed (OBIO) stake by 71% in Q3 2026, selling an estimated $8.72K and leaving 746 shares worth $4.64K. The position accounts for ﹤0.01% of the portfolio, ranked #8157.
Simplex Trading first reported a position in OBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.1K in Q2 2026. 91 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- Simplex Trading held 746 shares of Orchestra BioMed worth $4.64K as of Q3 2026.
- Simplex Trading sold 1,818 Orchestra BioMed shares in Q3 2026, an estimated $8.72K.
- Orchestra BioMed made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #8157 holding.
- Simplex Trading first reported a position in Orchestra BioMed in Q3 2025 and has held it in 4 quarters since.
- Simplex Trading's Orchestra BioMed position peaked at $11.1K in Q2 2026.
- 91 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.